The following lawsuits were filed at the Court of International Trade during the weeks of Dec. 16-22 and 23-29:
CBP issued the following releases on commercial trade and related matters:
The Drug Enforcement Administration is proposing to list e 4-chloromethcathinone, a central nervous system stimulant, under Schedule I of the Controlled Substances Act, it said in a notice released Dec. 27. “If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 4-chloromethcathinone.” Comments are due Jan. 29.
The Commerce Department released its preliminary affirmative antidumping determination Dec. 27 that disposable aluminum containers, pans, trays and lids from China (A-570-170) are being sold in the U.S. at less than fair value. Commerce found “critical circumstances” for all Chinese companies, and will retroactively suspend liquidation and impose antidumping duty cash deposit requirements for all subject merchandise as of Oct. 1.
DHS Homeland Security Investigations' congressional engagement led to the introduction of bills that would:
The U.S. charged three international drug traffickers last week with conspiracy to import fentanyl and methamphetamine precursor chemicals and importing a fentanyl precursor chemical, the U.S. Attorney's Office for the Southern District of New York announced. The indictment brought charges against Xiang Gao, a Chinese national; Oleksandr Klochkov, a Ukrainian national; and Igors Kricfalusijs, a Latvian national.
The Office of the U.S. Trade Representative opened an investigation into Chinese manufacturing of legacy (or foundational) semiconductors, "including to the extent that they are incorporated as components into downstream products for critical industries like defense, automotive, medical devices, aerospace, telecommunications, and power generation and the electrical grid."
Rep. Don Beyer, a long-time trade liberalization advocate, led a 90-minute hearing making the case against more tariffs in the second Trump administration, and Senate Budget Committee Chairman Sheldon Whitehouse, Majority Leader Chuck Schumer and Senate Finance Committee Chairman Ron Wyden slammed the economic impact of campaign tariff promises as the Democrats try to use their bully pulpits in the last week before Republicans will have control at both ends of Pennsylvania Avenue.
On Dec. 17, the FDA posted new and revised versions of the following Import Alerts (after not having posted new ones for a number of days) on the detention without physical examination of:
A five-year renewal of the Haiti HELP/HOPE trade preferences is the only tariff liberalization legislation that was attached to the federal spending bill that will keep the federal government open through mid-March.